WENDY RANDALL: Open Payments
NPI 1982183463 · SARATOGA SPGS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 17 payments from 11 companies in 2025. Trend: 2023 $359 · 2024 $747 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $93 |
| ABBVIE INC. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Indivior Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: SPRAVATO, VRAYLAR, INVEGA SUSTENNA, CAPLYTA, SUBLOCADE, ARISTADA, UZEDY, INGREZZA.
Industry payments across NY — which companies pay providers there.
